A review of issues surrounding quality of life among women with ovarian cancer

Functional Status in Turkish Women with Gynecological Cancer

“…Arriba et al (2010) reported the quality of life of women with ovarian cancer in stage I and II to be statistically significantly higher than in stage III and IV.…”

“…The social support of our patients seemed to be good in general: 81.3% received support from their husbands, 75.6% from their children, and 56.1% from their siblings (Table 1b). Social support is an important resource that can help cancer patients cope with their fear and doubts (Arriba et al, 2010). Eylen's study (2002) found that the subjects received social support from one or more persons during cancer treatment.…”

Inflammation and ovarian cancer

“…Subjective and objective evidence suggest that a third to half of patients developing EOC report symptoms at 3 or more months prior to diagnosis (Lurie et al, 2009;Arriba et al, 2010). Fatigue may be part of these symptom complex (Smith, 2006).…”

Palliative Care Opportunities for Women with Advanced Ovarian Cancer Associated with Intraperitoneal Chemotherapy

“…Table 1 presents the multidimensional framework that applies the NCP guidelines (which include the structure and process of care, the four domains of QOL, cultural aspects of care, attention to the needs of the imminently dying, and the ethical and legal aspects of care) to common IP OC symptoms reported in the literature reviewed above. 1,[3][4][5][6][7][8] Following the collection of quantitative reports of symptoms and QOL, each patient participated in an in-depth, semistructured interview. Final selection of tools and study design took into account concerns about overall participant burden for this vulnerable population.…”

“…While OC is responsive to chemotherapy and there have been improvements in available treatments, a significant number of women will either present with or progress to advanced disease. 1 Over 60% of women diagnosed with OC present with advanced disease (Stage III or IV) 2 and even those women diagnosed with early stage disease typically undergo multimodality therapy resulting in elevated distress from significant symptom and quality-of-life (QOL) concerns. [3][4][5][6][7][8] Recent randomized controlled trials 9,10 have demonstrated clinical benefit from the use of intraperitoneal (IP) chemotherapy for women with advanced OC.…”